Alpha Metallurgical Resources, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Alpha Metallurgical Resources, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.13B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.96B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $3.47B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $4.10B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $2.26B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $1.42B | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | $499.08M | Mar 18, 2020 |
| FY2019 | Sep 30, 2019 | $525.86M | Mar 18, 2020 |
| FY2019 | Jun 30, 2019 | $656.21M | Mar 18, 2020 |
| FY2019 | Mar 31, 2019 | $609.11M | Mar 18, 2020 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.12B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.95B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $3.46B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $4.09B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $2.25B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $1.41B | Feb 23, 2023 |
| FY2020 | Dec 31, 2019 | $2.00B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $2.02B | Mar 18, 2020 |
| FY2019 | Dec 31, 2017 | $1.64B | Mar 18, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($61.69M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $187.58M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $721.96M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.45B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $288.79M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | ($446.90M) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | ($140.94M) | Mar 18, 2020 |
| FY2019 | Sep 30, 2019 | ($68.53M) | Mar 18, 2020 |
| FY2019 | Jun 30, 2019 | ($113.66M) | Mar 18, 2020 |
| FY2019 | Mar 31, 2019 | $6.82M | Mar 18, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($61.37M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $227.85M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $863.09M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.58B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $359.20M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | ($170.69M) | Feb 23, 2023 |
| FY2020 | Dec 31, 2019 | ($169.10M) | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $193.76M | Mar 18, 2020 |
| FY2019 | Dec 31, 2017 | $182.36M | Mar 18, 2020 |
| FY2018 | Dec 31, 2016 | $35.39M | Apr 1, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $60.16M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $74.00M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $82.39M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $71.62M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $63.90M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $57.36M | Feb 23, 2023 |
| FY2020 | Dec 31, 2019 | $78.95M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $59.27M | Mar 18, 2020 |
| FY2019 | Dec 31, 2017 | $67.46M | Mar 18, 2020 |
| FY2018 | Dec 31, 2016 | $19.14M | Apr 1, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $144.93M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $579.92M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $851.16M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.48B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $174.94M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $129.24M | Feb 23, 2023 |
| FY2020 | Dec 31, 2019 | $131.88M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $158.38M | Mar 18, 2020 |
| FY2019 | Dec 31, 2017 | $314.26M | Mar 18, 2020 |
| FY2018 | Dec 31, 2016 | $21.46M | Apr 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.28B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.44B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $2.41B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.31B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $1.86B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.68B | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $2.30B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $2.75B | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $836.60M | Apr 1, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $735.13M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $789.21M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $832.13M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $882.72M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $1.31B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.48B | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $1.61B | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $1.67B | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $743.95M | Apr 1, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.55B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.65B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.57B | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $1.43B | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $546.91M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $200.10M | Feb 26, 2024 |
| FY2022 | Dec 31, 2019 | $696.12M | Feb 23, 2023 |
| FY2020 | Dec 31, 2018 | $1.07B | Mar 15, 2021 |
| FY2019 | Dec 31, 2017 | $92.65M | Mar 18, 2020 |
| FY2019 | Dec 31, 2016 | $37.22M | Mar 18, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.12M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $11.12M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $11.12M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $10.74M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $0 | Feb 23, 2023 |
| FY2020 | Dec 31, 2019 | $0 | Mar 15, 2021 |
| FY2020 | Dec 31, 2018 | $95.62M | Mar 15, 2021 |
| FY2018 | Dec 31, 2017 | $0 | Apr 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.09B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.16B | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $1.97B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.28B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | ($71.74M) | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($360.53M) | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | $86.81M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $403.13M | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | $103.96M | Apr 1, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $365.97M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $481.58M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $268.21M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $301.91M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $81.21M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $139.23M | Feb 23, 2023 |
| FY2020 | Dec 31, 2019 | $212.80M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | $233.60M | Mar 18, 2020 |
| FY2019 | Dec 31, 2017 | $141.92M | Mar 18, 2020 |
| FY2018 | Dec 31, 2016 | $127.95M | Apr 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.86M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.79M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $5.10M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $6.18M | Feb 26, 2024 |
| FY2021 | Dec 31, 2021 | $454.75M | Mar 7, 2022 |
| FY2020 | Dec 31, 2020 | $599.57M | Mar 15, 2021 |
| FY2019 | Dec 31, 2019 | $622.66M | Mar 18, 2020 |
| FY2018 | Dec 31, 2018 | $632.77M | Apr 1, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 14 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 51 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 82 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 15 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | (24) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | (7) | Mar 18, 2020 |
| FY2019 | Sep 30, 2019 | (3) | Mar 18, 2020 |
| FY2019 | Jun 30, 2019 | (5) | Mar 18, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 18, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (4) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 14 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 49 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 79 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 15 | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | (24) | Feb 23, 2023 |
| FY2019 | Dec 31, 2019 | (7) | Mar 18, 2020 |
| FY2019 | Sep 30, 2019 | (3) | Mar 18, 2020 |
| FY2019 | Jun 30, 2019 | (5) | Mar 18, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 18, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.81M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 13.02M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 12.94M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 15.55M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | 18.40M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 18.30M | Mar 7, 2022 |
| FY2020 | Dec 31, 2019 | 18.20M | Mar 15, 2021 |
| FY2019 | Dec 31, 2018 | 19.10M | Mar 18, 2020 |
| FY2018 | Dec 31, 2017 | 9.90M | Apr 1, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $26.85M | Feb 26, 2024 |
| FY2023 | Dec 15, 2023 | $6.51M | Feb 26, 2024 |
| FY2023 | Oct 3, 2023 | $6.74M | Feb 26, 2024 |
| FY2023 | Jul 5, 2023 | $7.00M | Feb 26, 2024 |
| FY2023 | Apr 3, 2023 | $6.60M | Feb 26, 2024 |